Liver metastases in gastroenteropancreatic neuroendocrine tumours - treatment methods
Author:
Open Access
- 1 January 2020
- journal article
- review article
- Published by Termedia Sp. z.o.o. in Gastroenterology Review
- Vol. 15 (3) , 207-214
Abstract
Surgical approaches that allow the safe treatment of multiple, bilateral, large tumours, and that combine extirpative, ablative and interventional therapies, have expanded the population of patients with neuroendocrine tumors (NET) liver metastases (LMs) who can benefit from aggressive treatment of their liver disease. Pre-treatment staging often includes the biochemical assessment of serologic markers such as serotonin, insulin, vasoactive intestinal peptide, and chromogranin, even in patients without clinically apparent hormonal excess. Radiofrequency ablation (RFA) is a technique that involves the use of thermal energy to induce coagulation necrosis, thereby destroying tumour cells. Resection plus RFA is increasingly used in patients with bilateral NET LMs. Resection is performed for large or dominant lesions, while ablation is used to treat small lesions. Hepatic arterial embolization, typically termed transarterial embolization, and transarterial chemoembolization have been shown to induce a reduction in tumour size and to ameliorate symptoms of excess hormonal secretion.Keywords
This publication has 49 references indexed in Scilit:
- Long-term survival after surgical management of neuroendocrine hepatic metastasesHPB, 2010
- Three Hundred and One Consecutive Extended Right HepatectomiesAnnals of Surgery, 2009
- Predictors of Long-Term Survival After Liver Transplantation for Metastatic Endocrine Tumors: An 85-Case French Multicentric ReportAmerican Journal of Transplantation, 2008
- Selection for Resection of Hepatocellular Carcinoma and Surgical Strategy: Indications for Resection, Evaluation of Liver Function, Portal Vein Embolization, and ResectionAnnals of Surgical Oncology, 2008
- Hepatic Resection for Noncolorectal Nonendocrine Liver MetastasesTransactions of the ... Meeting of the American Surgical Association, 2006
- Right Portal Vein Ligation: A New Planned Two-Step All-Surgical Approach for Complete Resection of Primary Gastrointestinal Tumors with Multiple Bilateral Liver MetastasesJournal of the American College of Surgeons, 2003
- Somatostatin receptor imagingSeminars in Nuclear Medicine, 2002
- Ki67, E-CADHERIN, AND p53 AS PROGNOSTIC INDICATORS OF LONG-TERM OUTCOME AFTER LIVER TRANSPLANTATION FOR METASTATIC NEUROENDOCRINE TUMORSTransplantation, 2002
- Portal vein embolization: rationale, technique and future prospectsBritish Journal of Surgery, 2001
- Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors.Hepatology, 1997